Document Detail


Maternal 25-hydroxyvitamin D and parathyroid hormone concentrations and offspring birth size.
MedLine Citation:
PMID:  16352684     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONTEXT: There is inconsistent evidence that maternal 25-hydroxyvitamin D [25-(OH)D] deficiency may impair fetal growth.
OBJECTIVE: The objective of the study was to examine the relationship between maternal 25-(OH)D and PTH concentrations at less than 16 and 28 wk gestation and offspring birth size.
DESIGN: This was an observational study.
SETTING: The study was set at a hospital antenatal clinic.
PARTICIPANTS: Women with singleton pregnancies, before 16 wk gestation, participated.
INTERVENTIONS: No interventions were used.
MAIN OUTCOME MEASURE: Knee-heel length at birth was the main outcome measure.
RESULTS: Altogether 374 of 475 (79%) women completed this study. We found no evident relationship between birth size measures and maternal 25-(OH)D or PTH at recruitment (approximately 11 wk). Gestation length was 0.7 wk (95% confidence interval -1.3, -0.1) shorter and knee-heel length was 4.3 mm smaller (-7.3, -1.3) in infants of 27 mothers with low 25-(OH)D (<28 nmol/liter) at 28-32 wk vs. babies whose mothers had higher concentrations. This latter difference was reduced to -2.7 mm (-5.4, -0.1) after adjustment for gestation length, suggesting some of the apparent growth deficit is explained by shorter gestation. There was no evidence that other birth measures were affected. Maternal PTH concentration at 28-32 wk was positively related to knee-heel length, birth weight, and mid-upper arm and calf circumferences. These associations were independent of 25-(OH)D concentration.
CONCLUSIONS: Low maternal 25-(OH)D in late pregnancy is associated with reduced intrauterine long bone growth and slightly shorter gestation. The long-term consequences for linear growth and health require follow-up. The positive relationship between maternal PTH and measures of infant size may relate to increased mineral demands by larger babies, but warrants further investigation.
Authors:
Ruth Morley; John B Carlin; Julie A Pasco; John D Wark
Related Documents :
10942464 - Does augmented growth impose an increased risk of fetal death?
2406654 - Sonographic growth measurements in triplet pregnancies.
17664904 - Weaning infants with malnutrition, including hiv.
17158414 - Exchangeable zinc pool size at birth is smaller in small-for-gestational-age than in ap...
21760584 - Neurobehavioral assessment as a predictor of neurodevelopmental outcome in preterm infa...
1711774 - Predictors of neurodevelopmental outcome following bronchopulmonary dysplasia.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2005-12-13
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  91     ISSN:  0021-972X     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  2006 Mar 
Date Detail:
Created Date:  2006-03-08     Completed Date:  2006-06-07     Revised Date:  2014-07-29    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  906-12     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Birth Weight*
Body Size
Calcifediol / blood*
Female
Humans
Infant, Newborn
Parathyroid Hormone / blood*
Pregnancy
Prenatal Care
Regression Analysis
Seasons
Skinfold Thickness
Chemical
Reg. No./Substance:
0/Parathyroid Hormone; P6YZ13C99Q/Calcifediol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295,...
Next Document:  The association of CTLA4 polymorphism with type 1 diabetes is concentrated in patients complicated w...